Transesophageal echocardiography (TEE) probe developer ImaCor has received the European CE Mark for its ClariTEE probe and Zura platform.
The ClariTEE is a miniaturized TEE probe specifically designed for hemodynamic assessment of high-acuity patients, according to the Garden City, NY-based vendor. ClariTEE and Zura both have received 510(k) clearance from the U.S. Food and Drug Administration.